Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Aug;41(2):164-8.
doi: 10.1136/gut.41.2.164.

Seroepidemiology of Helicobacter pylori infection and hepatitis A in a rural area: evidence against a common mode of transmission

Affiliations

Seroepidemiology of Helicobacter pylori infection and hepatitis A in a rural area: evidence against a common mode of transmission

F Luzza et al. Gut. 1997 Aug.

Abstract

Background and aims: Recent studies have shown that the age-specific seroprevalence of H pylori infection parallels hepatitis A (HAV), suggesting similar modes of transmission. The aim of this study was to investigate the seroepidemiology of H pylori and HAV in the same setting.

Patients: A sample of 705 resident subjects (273 men, age range 1-87 years, median 50) who attended the outpatient medical centre of the rural town of Cirò, Southern Italy (11,000 inhabitants) for blood testing were recruited.

Methods: All subjects completed a structured questionnaire. A serum sample was drawn from each subject and assayed for H pylori IgG by a validated in house enzyme linked immunosorbent assay. Antibodies to HAV were determined in 466 subjects (163 men, age range 1-87 years, median 49). A measure of agreement between H pylori and HAV seropositivity, the kappa statistic, was used.

Results: Overall, 446 (63%) subjects were seropositive for H pylori. Of the 466 subjects screened for both H pylori and HAV, 291 (62%) were seropositive for H pylori and 407 (87%) for HAV. Cross-tabulation of these data showed that 275 (59%) were seropositive and 43 (9%) seronegative for both H pylori and HAV, 16 (3%) were seropositive for H pylori, and 132 (28%) were seropositive for HAV (OR = 5.6, CI 3 to 10). There was a parallel, weakly correlated (r = 0.287) rise in the seroprevalence of the two infections with increasing age. However, the agreement between H pylori and HAV seropositivity was little better than chance (kappa = 0.21) and in those aged less than 20 years it was worse than chance (kappa = -0.064). Furthermore, multiple logistic regression analysis did not show any risk factor shared by both infections.

Conclusions: The correlation between H pylori and HAV reflects the age-specific seroprevalence of both infections rather than a true association. This study provides evidence against a common mode of transmission of H pylori and HAV.

PubMed Disclaimer

Figures

Figure 1
Figure 1
: Seroprevalence of H pylori and hepatitis A virus in the 466 subjects tested for both infections by age group: 1-10 years (n = 24), five H pylori positive, four HAV positive; 11-20 years (n = 20), eight H pylori positive, six HAV positive; 21-30 years (n = 62), 24 H pylori positive, 48 HAV positive; 31-40 years (n = 57), 36 H pylori positive, 55 HAV positive; 41-50 years (n = 76), 54 H pylori positive, 73 HAV positive; 51-60 years (n = 81), 58 H pylori positive, 77 HAV positive; 61-70 years (n = 89), 63 H pylori positive, 88 HAV positive; 71-80 years (n = 43), 33 H pylori positive, 42 HAV positive; >80 years (n = 14), 10 H pylori positive, 14 HAV positive.
Figure 2
Figure 2
: Seropositivity for H pylori and hepatitis A virus in the 466 subjects tested for both infections. The strength of agreement is calculated by κ statistic analysis according to Landis and Koch15 and shown in (A) the overall population and (B) in the subset of 44 subjects aged between 1 and 20 years. The seroprevalence of H pylori and hepatitis A virus was 62% and 87%, and 29% and 23%, respectively, in the two groups.

Similar articles

Cited by

References

    1. Dig Dis Sci. 1991 Aug;36(8):1084-8 - PubMed
    1. Am J Epidemiol. 1992 Mar 1;135(5):571-8 - PubMed
    1. Lancet. 1992 Nov 14;340(8829):1194-5 - PubMed
    1. Gastroenterol Clin North Am. 1993 Mar;22(1):169-82 - PubMed
    1. Gastroenterol Clin North Am. 1993 Mar;22(1):73-88 - PubMed

MeSH terms